Inhibiteurs

TL4830031 (8i), quinolone derivative, Axl inhibitor, IC50: 26 nM, blocks Axl phosphorylation, cell invasion & migration; for cancer research.

ER degrader 3 targets estrogen receptor, key in cell regulation, potential for cancer research.

STING agonist-22 (CF501) boosts vaccines by activating STING, inducing IFN-I and cytokines, aiding in SARS-CoV-2 research.

SK-575-NEG is a methylated form of SK-575, binds PARP1 (IC50: 2.64 nM), but doesn't induce PARP1 degradation up to 1 μM in cells.

9-Azido-Neu5DAz is a non-natural bifunctional carbohydrates as imaging agent.

Cap-dependent endonuclease-IN-22 is a powerful inhibitor of cap-dependent endonuclease (CEN) [1].

Cap-dependent endonuclease-IN-15: potent CEN inhibitor, halts influenza virus replication, aids viral research.

PLK1-IN-6: potent, selective PLK1 inhibitor, IC50 = 0.45 nM, hinders cancer cell growth.

TLQP-21 TFA is a VGF-derived peptide, C3aR1 agonist (mouse EC50: 10.3μM; human EC50: 68.8μM), that raises intracellular Ca2+ for nociception research.

gp91ds-tat is a useful organic compound for research related to life sciences and the catalog number is T35393.

PD-1/PD-L1 binder, Kd 0.51 μM; blocks interaction in flow cytometry at 1 mg/mL; inhibits tumors, extends mouse survival.

Azido-PEG12-t-butyl ester, a soluble PEG with azide/reactive t-butyl, forms triazoles via Click Chemistry; deprotectable in acid.